Current and Emerging Options for the Management of Inherited von Willebrand Disease

av Heijdra, Jessica M., Cnossen, Marjon H., Leebeek, Frank W. G.
I publikationen Drugs (2017)

Impact of extreme weight loss on factor VIII concentrate pharmacokinetics in haemophilia

av van Moort, Iris, Bukkems, Laura H, Nieuwenhuizen, Laurens, Cnossen, Marjon H
I publikationen BMJ Case Rep (2021)

Pharmacokinetic-guided dosing of factor VIII concentrate in a morbidly obese severe haemophilia A patient undergoing orthopaedic surgery

av Preijers, Tim, Laros-vanGorkom, Britta AP, Mathôt, Ron AA, Cnossen, Marjon H
I publikationen BMJ Case Rep (2019)

Circadian Variation of Plasminogen-Activator-Inhibitor-1 Levels in Children with Meningococcal Sepsis

av Boeddha, Navin P., Driessen, Gertjan J., Cnossen, Marjon H., Hazelzet, Jan A., Emonts, Marieke
I publikationen PLoS One (2016)

Pharmacokinetic-guided dosing of factor VIII concentrate in a patient with haemophilia during renal transplantation

av Hazendonk, Hendrika C A M, Kruip, Marieke J H A, Mathôt, Ron A A, Cnossen, Marjon H
I publikationen BMJ Case Rep (2016)

A randomized controlled trial studying the effectiveness of group medical appointments on self-efficacy and adherence in sickle cell disease (TEAM study): study protocol

av Madderom, Marlous J., Heijdra, Jessica, Utens, Elisabeth M. W. J., Polinder, Suzanne, Rijneveld, Anita W., Cnossen, Marjon H.
I publikationen BMC Hematol (2016)

Criteria for low von Willebrand factor diagnosis and risk score to predict future bleeding

av Atiq, Ferdows, Wuijster, Esmee, de Maat, Moniek P.M., Kruip, Marieke J.H.A., Cnossen, Marjon H., Leebeek, Frank W.G.
I publikationen J Thromb Haemost (2021)

Improving access to healthcare for paediatric sickle cell disease patients: a qualitative study on healthcare professionals’ views

av Houwing, Maite E., Buddenbaum, Marit, Verheul, Thijs C. J., de Pagter, Anne P. J., Philipsen, Jacobus N. J., Hazelzet, Jan A., Cnossen, Marjon H.
I publikationen BMC Health Serv Res (2021)

Population Pharmacokinetics of Clotting Factor Concentrates and Desmopressin in Hemophilia

av Preijers, Tim, Schütte, Lisette M., Kruip, Marieke J. H. A., Cnossen, Marjon H., Leebeek, Frank W. G., van Hest, Reinier M., Mathôt, Ron A. A.
I publikationen Clin Pharmacokinet (2020)

Analytical variation in factor VIII one‐stage and chromogenic assays: Experiences from the ECAT external quality assessment programme

av van Moort, Iris, Meijer, Piet, Priem‐Visser, Debby, van Gammeren, Adriaan J., Péquériaux, Nathalie C. V., Leebeek, Frank W. G., Cnossen, Marjon H., de Maat, Moniek P. M.
I publikationen Haemophilia (2018)

The one‐stage assay or chromogenic assay to monitor baseline factor VIII levels and desmopressin effect in non‐severe haemophilia A: Superiority or non‐inferiority?

av Schütte, Lisette M., Hodes, Luca S., van Moort, Iris, Stoof, Sara C. M., Leebeek, Frank W. G., Cnossen, Marjon H., de Maat, Moniek P. M., Kruip, Marieke J. H. A.
I publikationen Haemophilia (2020)

von Willebrand factor and factor VIII levels after desmopressin are associated with bleeding phenotype in type 1 VWD

av Atiq, Ferdows, Schütte, Lisette M., Looijen, Agnes E. M., Boender, Johan, Cnossen, Marjon H., Eikenboom, Jeroen, de Maat, Moniek P. M., Kruip, Marieke J. H. A., Leebeek, Frank W. G.
I publikationen Blood Adv (2019)

Identifying Children with HEreditary Coagulation disorders (iCHEC): a protocol for a prospective cohort study

av Stokhuijzen, Eva, Rand, Margaret L, Cnossen, Marjon H, Biss, Tina T, James, Paula D, Suijker, Monique H, Peters, Marjolein, van der Lee, Johanna H, Peters, Bram, Meijer, Alexander B, Blanchette, Victor S, Fijnvandraat, Karin
I publikationen BMJ Open (2018)

Silent cerebral infarcts in patients with sickle cell disease: a systematic review and meta-analysis

av Houwing, Maite E., Grohssteiner, Rowena L., Dremmen, Marjolein H. G., Atiq, Ferdows, Bramer, Wichor M., de Pagter, Anne P. J., Zwaan, C. Michel, White, Tonya J. H., Vernooij, Meike W., Cnossen, Marjon H.
I publikationen BMC Med (2020)

Bleeding severity in patients with rare bleeding disorders: real-life data from the RBiN study

av Saes, Joline L., Verhagen, Marieke J. A., Meijer, Karina, Cnossen, Marjon H., Schutgens, Roger E. G., Peters, Marjolein, Nieuwenhuizen, Laurens, van der Meer, Felix J. M., Kruis, Ilmar C., van Heerde, Waander L., Schols, Saskia E. M.
I publikationen Blood Adv (2020)

BMI is an important determinant of VWF and FVIII levels and bleeding phenotype in patients with von Willebrand disease

av Atiq, Ferdows, Fijnvandraat, Karin, van Galen, Karin P. M., Laros‐Van Gorkom, Britta A. P., Meijer, Karina, de Meris, Joke, Coppens, Michiel, Mauser‐Bunschoten, Eveline P., Cnossen, Marjon H., van der Bom, Johanna G., Eikenboom, Jeroen, Leebeek, Frank W. G.
I publikationen Am J Hematol (2019)

Von Willebrand Factor Multimer Densitometric Analysis: Validation of the Clinical Accuracy and Clinical Implications in Von Willebrand Disease

av Boender, Johan, Atiq, Ferdows, Cnossen, Marjon H., van der Bom, Johanna G., Fijnvandraat, Karin, de Meris, Joke, de Maat, Moniek P. M., van Galen, Karin P. M., Laros-van Gorkom, Britta A. P., Meijer, Karina, Eikenboom, Jeroen, Leebeek, Frank W. G.
I publikationen Hemasphere (2021)

Population pharmacokinetics of the von Willebrand factor–factor VIII interaction in patients with von Willebrand disease

av Bukkems, Laura H., Heijdra, Jessica M., de Jager, Nico C. B., Hazendonk, Hendrika C. A. M., Fijnvandraat, Karin, Meijer, Karina, Eikenboom, Jeroen C. J., Laros-van Gorkom, Britta A. P., Leebeek, Frank W. G., Cnossen, Marjon H., Mathôt, Ron A. A.
I publikationen Blood Adv (2021)

One piece of the puzzle: Population pharmacokinetics of FVIII during perioperative Haemate P(®)/Humate P(®) treatment in von Willebrand disease patients

av de Jager, Nico C. B., Bukkems, Laura H., Heijdra, Jessica M., Hazendonk, Carolien H. C. A. M., Fijnvandraat, Karin, Meijer, Karina, Eikenboom, Jeroen, Laros ‐ van Gorkom, Britta A. P., Leebeek, Frank W. G., Cnossen, Marjon H., Mathôt, Ron A. A., Collins, P. W.
I publikationen J Thromb Haemost (2019)

Dosing of factor VIII concentrate by ideal body weight is more accurate in overweight and obese haemophilia A patients

av van Moort, Iris, Preijers, Tim, Hazendonk, Hendrika C.A.M., Schutgens, Roger E.G., Laros‐van Gorkom, Britta A.P., Nieuwenhuizen, Laurens, van der Meer, Felix J.M., Fijnvandraat, Karin, Leebeek, Frank W.G., Meijer, Karina, Mathôt, Ron A.A., Cnossen, Marjon H.
I publikationen Br J Clin Pharmacol (2020)